Stallone et al. analyzed the potential of PTX-3 to discriminate tissue inflammation and benign prostatic hyperplasia from prostate cancer by evaluating both serum concentrations and tissular expression [36]. The gene discussed is PTX3; the disease is Familial prostate cancer.